Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

D. Koeberle; J.-F. Dufour; G. Demeter; Q. Li; K. Ribi; P. Samaras; P. Saletti; A.D. Roth; D. Horber; M. Buehlmann; A.D. Wagner; M. Montemurro; G. Lakatos; J. Feilchenfeldt; M. Peck-Radosavljevic; D. Rauch; B. Tschanz; G. Bodoky

doi:10.1093/annonc/mdw054

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

D. Koeberle
, J.-F. Dufour
, G. Demeter
, Q. Li
, K. Ribi
, P. Samaras
, P. Saletti
, A.D. Roth
, D. Horber
, M. Buehlmann
, A.D. Wagner
, M. Montemurro
, G. Lakatos
, J. Feilchenfeldt
, M. Peck-Radosavljevic
, D. Rauch
, B. Tschanz
, G. Bodoky

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	856-861
Journal	Annals of Oncology
Volume	27
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdw054
Publication status	Published - 1 May 2016

Access to Document

10.1093/annonc/mdw054

https://linkinghub.elsevier.com/retrieve/pii/S0923753419374344

Cite this

Koeberle, D., Dufour, J.-F., Demeter, G., Li, Q., Ribi, K., Samaras, P., Saletti, P., Roth, A. D., Horber, D., Buehlmann, M., Wagner, A. D., Montemurro, M., Lakatos, G., Feilchenfeldt, J., Peck-Radosavljevic, M., Rauch, D., Tschanz, B., & Bodoky, G. (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of Oncology, 27(5), 856-861. https://doi.org/10.1093/annonc/mdw054

@article{725b638573304a6ba771e9c6f92dc2d1,

title = "Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)",

author = "D. Koeberle and J.-F. Dufour and G. Demeter and Q. Li and K. Ribi and P. Samaras and P. Saletti and A.D. Roth and D. Horber and M. Buehlmann and A.D. Wagner and M. Montemurro and G. Lakatos and J. Feilchenfeldt and M. Peck-Radosavljevic and D. Rauch and B. Tschanz and G. Bodoky",

year = "2016",

month = may,

day = "1",

doi = "10.1093/annonc/mdw054",

language = "English",

volume = "27",

pages = "856--861",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "5",

}

Koeberle, D, Dufour, J-F, Demeter, G, Li, Q, Ribi, K, Samaras, P, Saletti, P, Roth, AD, Horber, D, Buehlmann, M, Wagner, AD, Montemurro, M, Lakatos, G, Feilchenfeldt, J, Peck-Radosavljevic, M, Rauch, D, Tschanz, B & Bodoky, G 2016, 'Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)', Annals of Oncology, vol. 27, no. 5, pp. 856-861. https://doi.org/10.1093/annonc/mdw054

TY - JOUR

T1 - Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

AU - Koeberle, D.

AU - Dufour, J.-F.

AU - Demeter, G.

AU - Li, Q.

AU - Ribi, K.

AU - Samaras, P.

AU - Saletti, P.

AU - Roth, A.D.

AU - Horber, D.

AU - Buehlmann, M.

AU - Wagner, A.D.

AU - Montemurro, M.

AU - Lakatos, G.

AU - Feilchenfeldt, J.

AU - Peck-Radosavljevic, M.

AU - Rauch, D.

AU - Tschanz, B.

AU - Bodoky, G.

PY - 2016/5/1

Y1 - 2016/5/1

U2 - 10.1093/annonc/mdw054

DO - 10.1093/annonc/mdw054

M3 - Article

SN - 0923-7534

VL - 27

SP - 856

EP - 861

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -